Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades
Related XOMA
Pandora,, Infinity Pharmaceuticals Lead Friday's After-Hours Movers
Servier Initiates Phase 2 Study of Gevokizumab in Patients With Diabetic Nephropathy
Related FMC
3 Niche ETFs Breaking Out
Benzinga's Top Downgrades

Analysts at McNicoll Lewis Valk downgraded XOMA (NASDAQ: XOMA) from “buy” to “hold.” The price target for XOMA has been lowered from $8 to $7. XOMA's shares closed at $6.43 yesterday.

Wells Fargo downgraded FMC (NYSE: FMC) from “outperform” to “market perform.” FMC's shares closed at $83.10 yesterday.

Analysts at Goldman Sachs downgraded Vipshop Holdings (NYSE: VIPS) from “buy” to “neutral.” The price target for Vipshop has been raised from $84.20 to $185. Vipshop's shares closed at $158.48 yesterday.

Keefe Bruyette & Woods downgraded U.S. Bancorp (NYSE: USB) from “outperform” to “market perform.” U.S. Bancorp's shares closed at $42.35 yesterday.

Latest Ratings for XOMA

Mar 2015Ladenburg ThalmannUpgradesNeutralBuy
Nov 2014Ladenburg ThalmannDowngradesBuyNeutral
Apr 2014McNicoll Lewis VlakUpgradesHoldBuy

View More Analyst Ratings for XOMA
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (FMC + USB)

Around the Web, We're Loving...